At Skinstitute, we are committed to the idea that every skin care experience should be supported by the power of science and medical expertise
Download the Shortform Chrome extension for your browser In this episode of the Huberman Lab podcast, psychologist Jamil Zaki examines the nature of cynicism - a pervasive mindset rooted in mistrust and the belief that others are motivated by self-interest
Jimnez-Loygorri JI, Villarejo-Zori B, Viedma-Poyatos , Zapata-Muoz J, Bentez-Fernndez R, Frutos-Lisn MD, et al
The SURMOUNT-1 trial, also published in the New England Journal of Medicine, found that participants lost an average of 16.0% of body weight at the 5mg dose, 21.4% at 10mg, and 22.5% at the highest 15mg dose over 72 weeks, compared to 2.4% in the placebo group with 89% to 96% of participants (depending on dose) reaching at least 5% weight loss
Safety Profile and Adverse Event Data Clinical trial safety data for retatrutide is broadly consistent with what has been reported for GLP-1 and GIP/GLP-1 classes, with a few nuances driven by the addition of glucagon receptor activity
